Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03392311
What this trial is testing

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis

Who this might be right for
Mesenchymal Stromal CellsPsoriasisDrug Effect+1 more
Guangdong Provincial Hospital of Traditional Chinese Medicine 8
Large-scale testing (Phase 3)Ended earlyNCT02786732
What this trial is testing

Study to Evaluate Broadlumab vs Placebo and Ustekinumab

Who this might be right for
Psoriasis
MedDerm Associates 15
Testing effectiveness (Phase 2)Study completedNCT00399906
What this trial is testing

BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 99
Large-scale testing (Phase 3)Study completedNCT01550744
What this trial is testing

Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen Biotech, Inc. 478
Testing effectiveness (Phase 2)Study completedNCT03463187
What this trial is testing

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate-to-severe Chronic Plaque Psoriasis
Jiangsu HengRui Medicine Co., Ltd. 211
Very early researchStudy completedNCT05282771
What this trial is testing

A Study Comparing Halobetasol Propionate and Tazarotene Topical Lotion 0.01%/0.045% to Duobrii® Lotion (Halobetasol Propionate and Tazarotene Lotion), 0.01%/0.045% (Reference Listed Drug) in the Treatment of Moderate to Severe Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries, Inc. 402
Post-approval studies (Phase 4)Study completedNCT01556672
What this trial is testing

Adalimumab-psoriasis and Small Bowel Lesions

Who this might be right for
Plaque PsoriasisCrohn's Disease
Innovaderm Research Inc. 100
Large-scale testing (Phase 3)Study completedNCT02445807
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Promius Pharma, LLC 265
Large-scale testing (Phase 3)Study completedNCT00111436
What this trial is testing

Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects

Who this might be right for
Psoriasis
Amgen 912
Large-scale testing (Phase 3)Study completedNCT00195689
What this trial is testing

Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Abbott 400
Large-scale testing (Phase 3)Study completedNCT01806597
What this trial is testing

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Who this might be right for
Moderate to Severe Palmoplantar Psoriasis
Novartis Pharmaceuticals 205
Testing effectiveness (Phase 2)Ended earlyNCT00954915
What this trial is testing

Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis

Who this might be right for
Psoriasis
MacroGenics 1
Testing effectiveness (Phase 2)Study completedNCT05344248
What this trial is testing

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

Who this might be right for
Moderate to Severe Psoriasis
Shanghai Junshi Bioscience Co., Ltd. 183
Testing effectiveness (Phase 2)Study completedNCT03591887
What this trial is testing

Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Affibody 108
Not applicableStudy completedNCT01425138
What this trial is testing

Systematic Review And Meta-Analysis Of Psoriasis Treatments.

Who this might be right for
Psoriasis
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT01622348
What this trial is testing

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Actively Extending Plaque PsoriasisModerate to Severe Plaque Psoriasis
Idera Pharmaceuticals, Inc. 44
Not applicableStudy completedNCT02310204
What this trial is testing

Therapeutic Education Program in Psoriasis

Who this might be right for
Psoriasis
University Hospital, Toulouse 187
Large-scale testing (Phase 3)Study completedNCT01206387
What this trial is testing

Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00645814
What this trial is testing

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 148
Large-scale testing (Phase 3)Study completedNCT00333034
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept 50 mg Once Weekly in Subjects With Psoriasis

Who this might be right for
Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation